MAPT and primary progressive aphasia: Importantly, while past studies incorporated heterogenous clinical and pathologic diagnoses, we report these findings in a cohort of participants diagnosed clinically with only PPA or bvFTD due to FTLD-tau and excluding significant comorbid pathologies.